Coldstream Capital Management Inc Bio Rad Laboratories, Inc. Transaction History

Coldstream Capital Management Inc

$4.64 Billion
Q1 2025

A detailed history of Coldstream Capital Management Inc transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Coldstream Capital Management Inc holds 642 shares of BIO stock, worth $145,689. This represents 0.0% of its overall portfolio holdings.

Number of Shares

642

Previous 862 25.52%

Holding current value

$145,689

Previous $283,000 44.88%

% of portfolio

0.0%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$243.0 - $367.0 $53,460 - $80,740	-220 Reduced 25.52%	642 $156,000
Q4 2024 Feb 14, 2025	BUY	$313.15 - $374.28 $4,384 - $5,239	14 Added 1.65%	862 $283,000
Q3 2024 Nov 15, 2024	BUY	$263.97 - $344.64 $5,279 - $6,892	20 Added 2.42%	848 $283,000
Q2 2024 Aug 07, 2024	SELL	$268.26 - $339.48 $6,438 - $8,147	-24 Reduced 2.82%	828 $226,000
Q1 2024 May 13, 2024	SELL	$304.11 - $351.99 $87,583 - $101,373	-288 Reduced 25.26%	852 $294,000
Q4 2023 Feb 09, 2024	BUY	$269.37 - $365.04 $129,297 - $175,219	480 Added 72.73%	1,140 $368,000
Q3 2023 Nov 02, 2023	SELL	$350.25 - $422.63 $12,609 - $15,214	-36 Reduced 5.17%	660 $236,000
Q2 2023 Aug 03, 2023	BUY	$359.49 - $486.4 $21,569 - $29,184	60 Added 9.43%	696 $263,000
Q1 2023 May 15, 2023	SELL	$418.69 - $503.0 $1,674 - $2,012	-4 Reduced 0.63%	636 $304,000
Q4 2022 Jan 10, 2023	BUY	$351.71 - $456.01 $17,585 - $22,800	50 Added 8.47%	640 $0
Q2 2022 Aug 08, 2022	SELL	$463.67 - $597.16 $201,232 - $259,167	-434 Closed	0 $0
Q2 2022 Aug 08, 2022	BUY	$463.67 - $597.16 $273,565 - $352,324	590 New	590 $292,000
Q1 2022 May 11, 2022	SELL	$524.57 - $735.42 $79,210 - $111,048	-151 Reduced 25.81%	434 $244,000
Q4 2021 Feb 11, 2022	BUY	$708.84 - $794.68 $414,671 - $464,887	585 New	585 $442,000
Q3 2020 Nov 16, 2020	SELL	$454.43 - $535.6 $298,560 - $351,889	-657 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$334.87 - $493.06 $11,720 - $17,257	-35 Reduced 5.06%	657 $296,000
Q1 2020 May 27, 2020	SELL	$320.01 - $409.07 $34,881 - $44,588	-109 Reduced 13.61%	692 $242,000
Q4 2019 Feb 13, 2020	BUY	$319.73 - $374.2 $959 - $1,122	3 Added 0.38%	801 $297,000
Q2 2019 Aug 15, 2019	BUY	$286.93 - $312.59 $7,173 - $7,814	25 Added 3.23%	798 $250,000
Q1 2019 May 10, 2019	BUY	$224.3 - $317.41 $173,383 - $245,357	773 New	773 $237,000
Q4 2018 Feb 26, 2019	SELL	$220.1 - $309.0 $188,845 - $265,122	-858 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$289.28 - $326.15 $248,202 - $279,836	858 New	858 $269,000

Others Institutions Holding BIO

# of Institutions

462

Shares Held

18.9M

Call Options Held

12.7K

Put Options Held

14.4K

View Full List

About BIO-RAD LABORATORIES, INC.

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $5.59B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

More about BIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Coldstream Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Coldstream Capital Management Inc with notifications on news.

Account

Coldstream Capital Management Inc Bio Rad Laboratories, Inc. Transaction History